Acumen Pharmaceuticals, Inc. (ABOS) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$121.33M | -18.6% |
| 2024 | -$102.33M | -95.4% |
| 2023 | -$52.37M | -22.2% |
| 2022 | -$42.86M | +57.4% |
| 2021 | -$100.61M | -1273.5% |
| 2020 | -$7.33M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$121.33M | -18.6% |
| 2024 | -$102.33M | -95.4% |
| 2023 | -$52.37M | -22.2% |
| 2022 | -$42.86M | +57.4% |
| 2021 | -$100.61M | -1273.5% |
| 2020 | -$7.33M | — |